SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950123-98-009940
Filing Date
1998-11-16
Accepted
1998-11-16 00:00:00
Documents
5

Document Format Files

Seq Description Document Type Size
1 ANTHRA PHARMACEUTICALS, INC. S-1/A 496756
2 FORM OF PROMOTIONAL SHARES LOCK-IN AGREEMENT EX-4.8 10113
3 FORM OF OPINION OF MORRISON & FOERSTER LLP EX-5 7338
4 CONSENT OF KPMG PEAT MARWICK LLP EX-23.1 906
5 FINANCIAL DATA SCHEDULE EX-27.1 2676
  Complete submission text file 0000950123-98-009940.txt   519697
Mailing Address 103 CARNEGIE CENTER SUITE 102 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 102 103 CARNEGIE CENTER SUITE 102 PRINCETON NJ 08540 6095141060
ANTHRA PHARMACEUTICALS INC (Filer) CIK: 0001054839 (see all company filings)

IRS No.: 223007972 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-1/A | Act: 33 | File No.: 333-47725 | Film No.: 98750079
SIC: 2835 In Vitro & In Vivo Diagnostic Substances